Search Results - "Ahlstrand, Erik"

Long-term molecular epidemiology of Staphylococcus epidermidis blood culture isolates from patients with hematological malignancies by Ahlstrand, Erik, Hellmark, Bengt, Svensson, Karolina, Söderquist, Bo

“…Staphylococcus epidermidis is an important cause of bloodstream infections in patients with hematological malignancies. Knowledge of the long-term epidemiology…”
Get full text

Flow Cytometric Measurement of Blood Cells with BCR-ABL1 Fusion Protein in Chronic Myeloid Leukemia by Löf, Liza, Arngården, Linda, Olsson-Strömberg, Ulla, Siart, Benjamin, Jansson, Mattias, Dahlin, Joakim S., Thörn, Ingrid, Christiansson, Lisa, Hermansson, Monica, Larsson, Anders, Ahlstrand, Erik, Wålinder, Göran, Söderberg, Ola, Rosenquist, Richard, Landegren, Ulf, Kamali-Moghaddam, Masood

“…Chronic myeloid leukemia (CML) is characterized in the majority of cases by a t(9;22)(q34;q11) translocation, also called the Philadelphia chromosome, giving…”
Get full text

P898: A PROSPECTIVE PHASE 2 STUDY TO ASSESS MINIMAL RESIDUAL DISEASE AFTER IXAZOMIB, LENALIDOMIDE, DEXAMETHASONE (IRD) TREATMENT FOR NEWLY DIAGNOSED TRANSPLANT ELIGIBLE MULTIPLE MYELOMA PATIENTS by Silvennoinen, Raija, Partanen, Anu, Waage, Anders, Pečeliūnas, Valdas, Schjesvold, Fredrik, Anttila, Pekka, Uttervall, Katarina, Säily, Marjaana, Putkonen, Mervi, Carlson, Kristina, Haukas, Einar, Sankelo, Marja, Szatkowski, Damian, Hansson, Markus, Marttila, Anu, Axelsson, Per, Svensson, Ronald, Lauri, Birgitta, Mikkola, Maija, Karlsson, Conny, Abelsson, Johanna, Ahlstrand, Erik, Sikiö, Anu, Klimkowska, Monika, Matuzeviciene, Reda, Hoyseter Fenstad, Mona, Ilveskero, Sorella, Nahi, Hareth

Get full text

Paired pulse facilitation of corticogeniculate EPSCs in the dorsal lateral geniculate nucleus of the rat investigated in vitro by Granseth, Björn, Ahlstrand, Erik, Lindström, Sivert

“…To investigate paired pulse facilitation of corticogeniculate EPSCs, whole-cell patch-clamp recordings were made from principal cells in the rat dorsal lateral…”
Get full text

Visual scoring of chest CT at hospital admission predicts hospitalization time and intensive care admission in Covid-19 by Ahlstrand, Erik, Cajander, Sara, Cajander, Per, Ingberg, Edvin, Löf, Erika, Wegener, Matthias, Lidén, Mats

“…Chest CT is prognostic in Covid-19 but there is a lack of consensus on how to report the CT findings. A chest CT scoring system, ÖCoS, was implemented in…”
Get full text

RT-PCR cycle threshold value in combination with visual scoring of chest computed tomography at hospital admission predicts outcome in COVID-19 by Ingberg, Edvin, Ahlstrand, Erik, Cajander, Per, Löf, Erika, Sundqvist, Martin, Wegener, Matthias, Lidén, Mats, Cajander, Sara

“…COVID-19 has a most variable prognosis. Several risk factors for an unfavourable outcome have been identified including extensive lung involvement on chest CT…”
Get full text

Highly Reduced Survival in ET and PV Patients with Vascular Complications during Follow-up - Real World Data from the Swedish MPN Registr by Lindgren, Marie, Ahlstrand, Erik, Pettersson, Helna, Liljeholm, Maria, Ravn-Landtblom, Anna, Scheding, Stefan, Andréasson, Björn, Samuelsson, Jan

“…Background Patients diagnosed with myeloproliferative neoplasms (MPNs) are at an increased risk of vascular events. A paucity of population-based studies…”
Get full text

BEAM or cyclophosphamide in autologous haematopoietic stem cell transplantation for relapsing-remitting multiple sclerosis by Silfverberg, Thomas, Zjukovskaja, Christina, Noui, Yassine, Carlson, Kristina, Burman, Joachim

“…The most widely used conditioning regimens in autologous haematopoietic stem cell transplantation (ASCT) for multiple sclerosis (MS) are BEAM with…”
Get full text

Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib – interim results from the DAstop2 trial by Flygt, Hjalmar, Söderlund, Stina, Richter, Johan, Saussele, Susanne, Koskenvesa, Perttu, Stenke, Leif, Mustjoki, Satu, Dimitrijevic, Andreja, Stentoft, Jesper, Majeed, Waleed, Roy, Lydia, Wolf, Dominik, Dreimane, Arta, Gjertsen, Bjørn Tore, Gedde-Dahl, Tobias, Ahlstrand, Erik, Markevärn, Berit, Hjorth-Hansen, Henrik, Janssen, Jeroen, Olsson-Strömberg, Ulla

“…Tyrosine kinase inhibitor (TKI) discontinuation in chronic myeloid leukemia (CML) has become part of routine care for patients with a sustained deep molecular…”
Get full text

Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study by Silfverberg, Thomas, Zjukovskaja, Christina, Ljungman, Per, Nahimi, Adjmal, Ahlstrand, Erik, Dreimane, Arta, Einarsdottir, Sigrun, Fagius, Jan, Iacobaeus, Ellen, Hägglund, Hans, Lange, Niclas, Lenhoff, Stig, Lycke, Jan, Mellergård, Johan, Piehl, Fredrik, Svenningsson, Anders, Tolf, Andreas, Cherif, Honar, Carlson, Kristina, Burman, Joachim

“…BackgroundA growing evidence base supports the use of autologous haematopoietic stem cell transplantation (aHSCT) for treatment of relapsing-remitting multiple…”
Get full text

Correction: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib – interim results from the DAstop2 trial by Flygt, Hjalmar, Söderlund, Stina, Richter, Johan, Saussele, Susanne, Koskenvesa, Perttu, Stenke, Leif, Mustjoki, Satu, Dimitrijevic, Andreja, Stentoft, Jesper, Majeed, Waleed, Roy, Lydia, Wolf, Dominik, Dreimane, Arta, Gjertsen, Bjørn Tore, Gedde-Dahl, Tobias, Ahlstrand, Erik, Markevärn, Berit, Hjorth-Hansen, Henrik, Janssen, Jeroen, Olsson-Strömberg, Ulla

Get full text

Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR—final report from AFTER-SKI by Richter, Johan, Lübking, Anna, Söderlund, Stina, Lotfi, Kourosh, Markevärn, Berit, Själander, Anders, Stenke, Leif, Deneberg, Stefan, Ahlstrand, Erik, Myhr-Eriksson, Kristina, Panayiotidis, Panayiotis, Gedde-Dahl, Tobias, Žáčková, Daniela, Mayer, Jiří, Olsson-Strömberg, Ulla, Mahon, Francois-Xavier, Saussele, Susanne, Hjorth-Hansen, Henrik, Koskenvesa, Perttu

Get full text

Inflammatory functional iron deficiency common in myelofibrosis, contributes to anaemia and impairs quality of life. From the Nordic MPN study Group by Birgegard, Gunnar, Samuelsson, Jan, Ahlstrand, Erik, Ejerblad, Elisabeth, Enevold, Christian, Ghanima, Waleed, Hasselbalch, Hans, Nielsen, Claus H., Knutsen, Håvar, Pedersen, Ole B., Sørensen, Anders, Andreasson, Björn

“…Objectives The study investigates the hypothesis that inflammation in myelofibrosis (MF) like in myeloma and lymphoma, may disturb iron distribution and…”
Get full text

Survival and risk of vascular complications in myelofibrosis—A population‐based study from the Swedish MPN group by Lindgren, Marie, Andréasson, Björn, Samuelsson, Jan, Pettersson, Helna, Enblom‐Larsson, Anneli, Ravn‐Landtblom, Anna, Scheding, Stefan, Bentham, Carolina, Ahlstrand, Erik

“…Objective To gain knowledge of underlying risk factors for vascular complications and their impact on life expectancy in myelofibrosis. Methods From a cohort…”
Get full text

Highly reduced survival in essential thrombocythemia and polycythemia vera patients with vascular complications during follow‐up by Ahlstrand, Erik, Samuelsson, Jan, Lindgren, Marie, Pettersson, Helna, Liljeholm, Maria, Ravn‐Landtblom, Anna, Scheding, Stefan, Andréasson, Björn

“…Objective To explore the relative importance of risk factors, treatments, and blood counts for the occurrence of vascular complications and their impact on…”
Get full text

A phase II study of vorinostat (MK‐0683) in patients with polycythaemia vera and essential thrombocythaemia by Andersen, Christen L., McMullin, Mary F., Ejerblad, Elisabeth, Zweegman, Sonja, Harrison, Claire, Fernandes, Savio, Bareford, David, Knapper, Steven, Samuelsson, Jan, Löfvenberg, Eva, Linder, Olle, Andreasson, Bjørn, Ahlstrand, Erik, Jensen, Morten K., Bjerrum, Ole W., Vestergaard, Hanne, Larsen, Herdis, Klausen, Tobias W., Mourits‐Andersen, Torben, Hasselbalch, Hans C.

“…Summary Inhibition of histone deacetylases may be an important target in patients with myeloproliferative neoplasms. This investigator‐initiated,…”
Get full text

P-222: A prospective phase 2 study to assess minimal residual disease after ixazomib plus lenalidomide plus dexamethasone (IRd) treatment for newly diagnosed transplant eligible multiple myeloma patients by Silvennoinen, Raija, Waage, Anders, Peceliunas, Valdas, Schjesvold, Fredrik, Anttila, Pekka, Uttervall, Katarina, Säily, Marjaana, Putkonen, Mervi, Carlson, Kristina, Haukas, Einar, Sankelo, Marja, Partanen, Anu, Szatkowski, Damian, Hansson, Markus, Marttila, Anu, Svensson, Ronald, Axelsson, Per, Lauri, Birgitta, Mikkola, Maija, Karlsson, Conny, Abelsson, Johanna, Ahlstrand, Erik, Sikiö, Anu, Nahi, Hareth

Get full text

A Prospective Phase 2 Study to Assess Minimal Residual Disease after Ixazomib, Lenalidomide and Dexamethasone Treatment for Newly Diagnosed Transplant Eligible Multiple Myeloma Patients by Silvennoinen, Raija Helena, Waage, Anders, Peceliunas, Valdas, Schjesvold, Fredrik, Anttila, Pekka, Säily, Marjaana, Putkonen, Mervi, Carlson, Kristina, Haukaas, Einar, Sankelo, Marja, Partanen, Anu, Szatkowski, Damian L., Hansson, Markus, Marttila, Anu, Ahlberg, Lucia, Axelsson, Per, Lauri, Birgitta, Mikkola, Maija Helena, Karlsson, Conny, Abelsson, Johanna, Ahlstrand, Erik, Sikiö, Anu, Klimkowska, Monika, Matuzeviciene, Reda, Hoysaeter Fenstad, Mona, Ilveskero, Sorella, Nahi, Hareth

“…Introduction Autologous stem cell transplantation (ASCT) combined with novel agents is considered as the standard treatment for eligible patients < 70(-75)…”
Get full text

Ixazomib, Lenalidomide, and Dexamethasone (IRD) Treatment with Cytogenetic Risk-Based Maintenance in Transplant-Eligible Myeloma: A Phase 2 Multicenter Study by the Nordic Myeloma Study Group by Partanen, Anu, Waage, Anders, Peceliunas, Valdas, Schjesvold, Fredrik, Anttila, Pekka, Säily, Marjaana, Uttervall, Katarina, Putkonen, Mervi, Carlson, Kristina, Haukas, Einar, Sankelo, Marja, Szatkowski, Damian, Hansson, Markus, Marttila, Anu, Svensson, Ronald, Axelsson, Per, Lauri, Birgitta, Mikkola, Maija, Karlsson, Conny, Abelsson, Johanna, Ahlstrand, Erik, Sikiö, Anu, Klimkowska, Monika, Matuzeviciene, Reda, Fenstad, Mona Hoysaeter, Ilveskero, Sorella, Pelliniemi, Tarja-Terttu, Nahi, Hareth, Silvennoinen, Raija

“…Scarce data exist on double maintenance in transplant-eligible high-risk (HR) newly diagnosed multiple myeloma (NDMM) patients. This prospective phase 2 study…”
Get full text

Glycopeptide resistance in coagulase-negative staphylococci isolated in blood cultures from patients with hematological malignancies during three decades by Ahlstrand, E., Svensson, K., Persson, L., Tidefelt, U., Söderquist, B.

“…The aim of this study was to determine if there was a long-term increase in glycopeptide minimum inhibitory concentration (MIC) values, MIC creep, among…”
Get full text